Amalgamated Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.04M | Buy |
88,001
+1,672
| +2% | +$91.6K | 0.03% | 437 |
|
|
2026
Q1 | $4.88M | Buy |
86,329
+949
| +1% | +$55.3K | 0.04% | 436 |
|
|
2025
Q4 | $5.07M | Sell |
85,380
-2,187
| -2% | -$119K | 0.04% | 407 |
|
|
2025
Q3 | $4.74M | Buy |
87,567
+98
| +0.1% | +$5.61K | 0.03% | 439 |
|
|
2025
Q2 | $4.81M | Buy |
87,469
+149
| +0.2% | +$8.77K | 0.04% | 412 |
|
|
2025
Q1 | $6.17M | Sell |
87,320
-3,728
| -4% | -$251K | 0.05% | 295 |
|
|
2024
Q4 | $5.99M | Buy |
91,048
+382
| +0.4% | +$25.6K | 0.05% | 320 |
|
|
2024
Q3 | $6.37M | Sell |
90,666
-5,256
| -5% | -$439K | 0.05% | 308 |
|
|
2024
Q2 | $7.9M | Buy |
95,922
+85,177
| +793% | +$7.09M | 0.07% | 233 |
|
|
2024
Q1 | $938K | Sell |
10,745
-5,619
| -34% | -$503K | 0.01% | 1068 |
|
|
2023
Q4 | $1.58M | Sell |
16,364
-4,303
| -21% | -$381K | 0.01% | 992 |
|
|
2023
Q3 | $1.83M | Buy |
20,667
+2,439
| +13% | +$217K | 0.02% | 907 |
|
|
2023
Q2 | $1.58M | Sell |
18,228
-302
| -2% | -$28.4K | 0.01% | 969 |
|
|
2023
Q1 | $1.8M | Buy |
18,530
+91
| +0.5% | +$9.43K | 0.02% | 905 |
|
|
2022
Q4 | $1.91M | Buy |
18,439
+123
| +0.7% | +$11.5K | 0.02% | 915 |
|
|
2022
Q3 | $1.55M | Sell |
18,316
-1,197
| -6% | -$107K | 0.02% | 945 |
|
|
2022
Q2 | $1.62M | Buy |
19,513
+1,497
| +8% | +$119K | 0.02% | 943 |
|
|
2022
Q1 | $1.39M | Sell |
18,016
-1,097
| -6% | -$91.8K | 0.01% | 1075 |
|
|
2021
Q4 | $1.69M | Sell |
19,113
-191
| -1% | -$15.8K | 0.01% | 1018 |
|
|
2021
Q3 | $1.49M | Sell |
19,304
-1,751
| -8% | -$138K | 0.01% | 1063 |
|
|
2021
Q2 | $1.76M | Buy |
21,055
+12,244
| +139% | +$971K | 0.01% | 1023 |
|
|
2021
Q1 | $665K | Sell |
8,811
-476
| -5% | -$38.9K | 0.02% | 817 |
|
|
2020
Q4 | $814K | Sell |
9,287
-136
| -1% | -$10.8K | 0.03% | 679 |
|
|
2020
Q3 | $717K | Sell |
9,423
-153
| -2% | -$15.5K | 0.03% | 639 |
|
|
2020
Q2 | $1.18M | Sell |
9,576
-17,977
| -65% | -$1.79M | 0.05% | 351 |
|
|
2020
Q1 | $2.33M | Sell |
27,553
-964
| -3% | -$83.1K | 0.06% | 310 |
|
|
2019
Q4 | $2.41M | Buy |
28,517
+1,338
| +5% | +$101K | 0.04% | 408 |
|
|
2019
Q3 | $1.83M | Buy |
27,179
+5,868
| +28% | +$452K | 0.04% | 475 |
|
|
2019
Q2 | $1.82M | Sell |
21,311
-2,837
| -12% | -$243K | 0.04% | 451 |
|
|
2019
Q1 | $2.15M | Buy |
24,148
+712
| +3% | +$66K | 0.05% | 355 |
|
|
2018
Q4 | $2M | Sell |
23,436
-754
| -3% | -$71.7K | 0.06% | 317 |
|
|
2018
Q3 | $2.35M | Sell |
24,190
-569
| -2% | -$56.8K | 0.06% | 313 |
|
|
2018
Q2 | $2.33M | Buy |
24,759
+1,954
| +9% | +$171K | 0.06% | 315 |
|
|
2018
Q1 | $1.85M | Buy |
22,805
+2,509
| +12% | +$215K | 0.05% | 412 |
|
|
2017
Q4 | $1.81M | Buy |
20,296
+2,052
| +11% | +$178K | 0.05% | 402 |
|
|
2017
Q3 | $1.7M | Buy |
18,244
+402
| +2% | +$35.5K | 0.05% | 362 |
|
|
2017
Q2 | $1.62M | Buy |
17,842
+7,628
| +75% | +$694K | 0.05% | 373 |
|
|
2017
Q1 | $897K | Sell |
10,214
-5,445
| -35% | -$484K | 0.04% | 491 |
|
|
2016
Q4 | $1.3M | Buy |
15,659
+3,399
| +28% | +$292K | 0.06% | 354 |
|
|
2016
Q3 | $1.13M | Buy |
12,260
+456
| +4% | +$42.9K | 0.07% | 307 |
|
|
2016
Q2 | $1.09M | Buy |
11,804
+6,500
| +123% | +$553K | 0.06% | 323 |
|
|
2016
Q1 | $437K | Buy |
5,304
+1,521
| +40% | +$124K | 0.04% | 608 |
|
|
2015
Q4 | $396K | Sell |
3,783
-1,226
| -24% | -$128K | 0.05% | 580 |
|
|
2015
Q3 | $528K | Buy |
5,009
+125
| +3% | +$16.7K | 0.06% | 470 |
|
|
2015
Q2 | $668K | Buy |
4,884
+375
| +8% | +$46.5K | 0.07% | 378 |
|
|
2015
Q1 | $562K | Buy |
4,509
+866
| +24% | +$91.8K | 0.07% | 361 |
|
|
2014
Q4 | $329K | Buy |
3,643
+141
| +4% | +$11.7K | 0.05% | 531 |
|
|
2014
Q3 | $253K | Buy |
3,502
+276
| +9% | +$18.1K | 0.04% | 675 |
|
|
2014
Q2 | $201K | Sell |
3,226
-64
| -2% | -$3.87K | 0.03% | 819 |
|
|
2014
Q1 | $224K | Sell |
3,290
-71
| -2% | -$5.23K | 0.04% | 701 |
|
|
2013
Q4 | $236K | Buy |
+3,361
| New | +$228K | 0.04% | 682 |
|
Other funds holding BMRN
AIM
FWIA
Amalgamated Bank's BMRN Position: Q2 2026 in Review
Amalgamated Bank increased its BioMarin Pharmaceuticals (BMRN) stake by 1.9% in Q2 2026, buying an estimated $91.6K and bringing the position to 88,001 shares worth $5.04M. The position accounts for 0.03% of the portfolio, ranked #437.
Amalgamated Bank first reported a position in BMRN in Q4 2013 and has held it in 51 quarters since. The position peaked at $7.9M in Q2 2024. 257 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- Amalgamated Bank held 88,001 shares of BioMarin Pharmaceuticals worth $5.04M as of Q2 2026.
- Amalgamated Bank bought 1,672 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $91.6K.
- BioMarin Pharmaceuticals made up 0.03% of Amalgamated Bank's portfolio in Q2 2026, its #437 holding.
- Amalgamated Bank first reported a position in BioMarin Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
- Amalgamated Bank's BioMarin Pharmaceuticals position peaked at $7.9M in Q2 2024.
- 257 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.